Virginia Mason in partnership with Benaroya Research Institute at Virginia Mason (BRI) is the northwest’s leader in offering clinical studies to patients. Together we are leading the way in the discovery of innovative treatments and diagnostic tools for arthritis, cancer, diabetes, HIV/AIDS, and other conditions in immunology, cardiology and urology.
The Benaroya Research Institute at Virginia Mason seeks to discover the causes and cures of human diseases. BRI is the base for the national AIDS-Related Malignancy Consortium, the Arthritis Clinical Research Unit, Cancer Clinical Research Unit and an internationally recognized Diabetes Center. BRI has helped identify the first known gene for type 2 (adult) diabetes, worked with other Seattle institutions to launch the islet transplantation program and houses a seven-bed Clinical Research Center for patients and families participating in clinical trials and research studies.
The discovery of new treatments is impossible without the support of patients participating in clinical studies. We carefully match individual patient's needs with each study's criteria to determine eligibility. Participants in the studies have access to cutting-edge care that is not available in many medical centers.
Please visit Benaroya Research Institute online for more information on clinical studies and to find out how you can take part in the discovery of new treatments while getting the most innovative health care in the region.